Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
REYKJAVIK, Iceland, Nov. 9, 2006 (PRIMEZONE) -- Actavis Group ("ACT"), the international generic pharmaceuticals company, announces its results for the third quarter ended 30 September,...
-
CRANFORD, N.J. and REYKJAVIK, Iceland, Nov. 6, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announced that Actavis U.S., its manufacturing and...
-
REYKJAVIK, Iceland, Oct. 20, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, announces that a total of 20.8% of PLIVA's share capital that Actavis...
-
REYKJAVIK, Iceland, Sept. 18, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, has noted the increased offer published on September 11th, to acquire...
-
REYKJAVIK, Iceland, Sept. 14, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, announced today that it has received a warning letter from the U.S. Food...
-
REYKJAVIK, Iceland, Aug. 31, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceutical company, today announces that it has increased its offer to acquire the Croatian...
-
REYKJAVIK, Iceland, Aug. 11, 2006 (PRIMEZONE) -- Actavis Group hf. (ICEX:ACT), the international generic pharmaceuticals company, announces following its earnings release this morning, that the...
-
REYKJAVIK, Aug. 10, 2006 (PRIMEZONE) -- Actavis Group ("ACT") (ICEX:ACT), the international generic pharmaceuticals company, announces its results for the second quarter ended 30 June 2006. Sindan,...
-
REYKJAVIK, Iceland, Aug. 10, 2006 (PRIMEZONE) -- Actavis Group hf. (ICEX:ACT), the international generic pharmaceuticals company, announces that it has submitted, on 9 August 2006, a request for the...
-
REYKJAVIK, Iceland, Aug. 3, 2006 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food &...